Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marc Classe

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Bulletin Du Cancer|September 24, 2021
[Academic carriers in oncology and radiotherapy: Update for the readers of Bulletin du Cancer]Gilles Calais, Jean-Marc Classe, Michel Ducreux, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 12, 2012
Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric StudyMathieu Luyckx, Eric Leblanc, Thomas Filleron, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2017
Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohortViolaine Forissier, Agnès Tallet, Monique Cohen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 14, 2024
Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective studyNavid Mokarram Dorri, Mathilde Del, Francesco Cannone, et al.
Plos One|July 13, 2011
Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapyAhmed Hamaï, Karine Duperrier-Amouriaux, Pascale Pignon, et al.
Breast (Edinburgh, Scotland)|February 12, 2023
Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysisOndine Dufour, Gilles Houvenaeghel, Jean-Marc Classe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 21, 2021
Laparoscopic management of advanced epithelial ovarian cancer after neoadjuvant chemotherapy: a phase II prospective multicenter non-randomized trial (the CILOVE study)Christophe Pomel, Cherrif Akladios, Eric Lambaudie, et al.
Annals of Surgical Oncology|February 23, 2023
Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian CancerLisa Frankinet, Aditi Bhatt, Vincent Alcazer, et al.
Plos One|January 29, 2016
Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?Fabien Vidal, Paul Guerby, Mathieu Luyckx, et al.
Frontiers in Oncology|January 1, 2024
Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatmentGilles Houvenaeghel, Monique Cohen, Anthony Gonçalves, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Bulletin Du Cancer|September 24, 2021
[Academic carriers in oncology and radiotherapy: Update for the readers of Bulletin du Cancer]Gilles Calais, Jean-Marc Classe, Michel Ducreux, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 12, 2012
Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric StudyMathieu Luyckx, Eric Leblanc, Thomas Filleron, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2017
Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohortViolaine Forissier, Agnès Tallet, Monique Cohen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 14, 2024
Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective studyNavid Mokarram Dorri, Mathilde Del, Francesco Cannone, et al.
Plos One|July 13, 2011
Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapyAhmed Hamaï, Karine Duperrier-Amouriaux, Pascale Pignon, et al.
Breast (Edinburgh, Scotland)|February 12, 2023
Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysisOndine Dufour, Gilles Houvenaeghel, Jean-Marc Classe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 21, 2021
Laparoscopic management of advanced epithelial ovarian cancer after neoadjuvant chemotherapy: a phase II prospective multicenter non-randomized trial (the CILOVE study)Christophe Pomel, Cherrif Akladios, Eric Lambaudie, et al.
Annals of Surgical Oncology|February 23, 2023
Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian CancerLisa Frankinet, Aditi Bhatt, Vincent Alcazer, et al.
Plos One|January 29, 2016
Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?Fabien Vidal, Paul Guerby, Mathieu Luyckx, et al.
Frontiers in Oncology|January 1, 2024
Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatmentGilles Houvenaeghel, Monique Cohen, Anthony Gonçalves, et al.
Pageof 11